HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2025)
HUTCHMED (China) (HCM) reported Accumulated Expenses of $29.1 million for Q4 2025, down 2.28% year-over-year from $29.8 million in Q4 2024, and down 2.28% quarter-over-quarter from $29.8 million in Q4 2024.
HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Accumulated Expenses data on file, last reported at $29.1 million in Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $29.1 million, down 2.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $29.1 million (down 2.28% YoY), and the FY2025 annual result was $29.1 million, down 2.28% from the prior year.
- Accumulated Expenses retreated to $29.1 million in Q4 2025 per HCM's latest filing, from $29.8 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $29.8 million in Q4 2024 and troughed at $8.4 million in Q4 2021.
- A 5-year average of $21.0 million and a median of $21.4 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2022: Accumulated Expenses sank 61.73% in 2021, then jumped 154.28% in 2022.
- A 5-year view of Accumulated Expenses shows it stood at $8.4 million in 2021, then soared by 154.28% to $21.4 million in 2022, then declined by 23.61% to $16.3 million in 2023, then soared by 82.07% to $29.8 million in 2024, then dropped by 2.28% to $29.1 million in 2025.
- Business Quant data shows HCM's Accumulated Expenses at $29.1 million in Q4 2025, $29.8 million in Q4 2024, and $16.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.07 Mn |
| Dec 31, 2024 | 29.75 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Dec 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | 8.41 Mn |
| Dec 31, 2020 | 21.98 Mn |
| Dec 31, 2019 | 3.34 Mn |
| Dec 31, 2018 | 4.68 Mn |
| Dec 31, 2017 | 4.12 Mn |
| Dec 31, 2016 | 4.34 Mn |
| Dec 31, 2015 | 4.43 Mn |